Neurodegenerative diseases and tea
Barranco-Quintana, J.L.; Allam, M.F.; Del Castillo, A.S.; Navajas, R.F.-C.
Revista de Neurologia 44(6): 381-382
2007
ISSN/ISBN: 0210-0010 PMID: 17385176 Document Number: 614977
Document emailed within 1 workday
Related Documents
Morselli, L.L.; Bogazzi, F.; Cecconi, E.; Genovesi, M.; Martino, E.; Gasperi, M. 2008: Hypopituitarism (GHD) and neurodegenerative diseases Journal of Endocrinological Investigation 31(9 Suppl): 39-43Segura, T.; Galindo, M.F.; Rallo-Gutiérrez, B.; Ceña, V.; Jordán, J. 2003: Pharmacological targets in neurodegenerative diseases Revista de Neurologia 36(11): 1047-1057
Bain, L. 1996: Neurodegenerative diseases: sustaining hope Professional Nurse 11(8): 515-516
Zhao, B.; Zhong, M.; Jin, K. 2008: Neurogenesis and neurodegenerative diseases in human Panminerva Medica 50(1): 55-64
De la Monte, S.M.; Sohn, Y.K.; Ganju, N.; Wands, J.R. 1998: P53- and CD95-associated apoptosis in neurodegenerative diseases Laboratory Investigation; a Journal of Technical Methods and Pathology 78(4): 401-411
Iribarren, P.; Cui, Y.-H.; Le, Y.; Wang, J.M. 2002: The role of dendritic cells in neurodegenerative diseases Archivum Immunologiae et Therapiae Experimentalis 50(3): 187-196
Ingelsson, M.; Nilsson, L.; Basun, H.; Aquilonius, S.-M.; Lannfelt, L. 2005: Conformationally altered proteins cause neurodegenerative diseases Lakartidningen 102(47): 3542
Jain, S.; Maheshwari, M.C. 1985: Neurodegenerative diseases of infancy and childhood. (Part I) Indian Pediatrics 22(10): 767-775
Martin-Rendon, E.; Azzouz, M.; Mazarakis, N.D. 2001: Lentiviral vectors for the treatment of neurodegenerative diseases Current Opinion in Molecular Therapeutics 3(5): 476-481
Levy, R. 2000: Neuropsychological evaluation: a useful clinical tool for neurodegenerative diseases Revue Neurologique (Paris) 156(4): 415-426
Hatakeyama, S. 2006: Neurodegenerative diseases regulated by ubiquitin-proteasome system Rinsho Shinkeigaku 46(11): 890-892
Cavallucci, V.; Nobili, A.; D'Amelio, M. 2013: Emerging role of mitochondria dysfunction in the onset of neurodegenerative diseases Journal of Biological Regulators and Homeostatic Agents 27(2 Suppl): 1-9
Nivet-Antoine, V.; Coulhon, M-P.; Le Denmat, C.; Hamon, B.; Dulcire, X.; Lefebvre, M.; Piette, F.; Davous, P.; Durand, D.; Duchassaing, D. 2003: Apolipoprotein E and bleomycin hydrolase. Polymorphisms: association with neurodegenerative diseases Annales de Biologie Clinique 61(1): 61-67
Madrazo, I.; Castrejón, H.; Franco-Bourland, R.E. 1994: Human brain drafting: an approach to the treatment of neurodegenerative diseases Surgical Technology International 3: 493-499
Mayer, R.J.; Lowe, J.; Lennox, G.; Doherty, F.; Landon, M. 1989: Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases Progress in Clinical and Biological Research 317: 809-818
Shoham, S.; Youdim, M.B. 2000: Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases Cellular and Molecular Biology 46(4): 743-760
Wurtman, R.J.; Blusztajn, J.K.; Ulus, I.H.; Coviella, I.L.; Buyukuysal, R.L.; Growdon, J.H.; Slack, B.E. 1990: Choline metabolism in cholinergic neurons: implications for the pathogenesis of neurodegenerative diseases Advances in Neurology 51: 117-125
Gołab-Janowska, M.; Honczarenko, K.; Gawrońska-Szklarz, B.; Potemkowski, A. 2007: The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia Neurologia i Neurochirurgia Polska 41(5): 388-394
Chiba, T.; Tanaka, K. 2005: Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases Rinsho Shinkeigaku 45(11): 976-978
Borza, L.R. 2014: A review on the cause-effect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 118(1): 19-27